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Abstract 
Cystic mesotheliomas are benign neoplasms, often seen in the parietal and visceral 
peritoneum, omentum and pelvic organs, and are exceedingly rare in the liver. It is 
however important to be familiar with the radiological findings of this tumour because 
the signal-intensity and enhancement pattern of this tumor are unusual and not typical for 
any of the more frequently seen mass lesions.  In our patient, characteristic imaging 
findings on dynamic contrast-enhanced MRI and histopathological confirmation with 
appropriate immunohistochemical markers facilitated a correct diagnosis. We herein 
describe the clinical, imaging and histolopathological features, pathogenesis, differential 
diagnosis and treatment of benign cystic mesothelioma involving posterior segment of 
the right lobe of the liver.  
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Introduction 
 
Cystic mesotheliomas are benign neoplasms that usually occur in young to middle aged 
women [1]. They are often seen in the parietal and visceral peritoneum, omentum, and 
pelvic organs, and are exceedingly rare in the liver [2-6]. The imaging findings are 
frequently non-specific and therefore do not allow definitive diagnosis. We herein report 
a case of benign cystic mesothelioma involving the right lobe of the liver, which 
presented as a mass incidentally detected on ultrasound (US), further evaluated by 
magnetic resonance imaging (MRI) and conclusively diagnosed by percutaneous core 
biopsy of the liver. We discuss the clinical, imaging and histolopathological findings, 
pathogenesis, differential diagnosis and treatment of this rare entity. 
 
 
Case report 
 
A 30-year-old woman with 20 years history of ulcerative colitis (UC) without personal or 
family history of liver disease presented with a UC flare.  Physical examination revealed 
no palpable liver, spleen or hepatic mass. Laboratory values including serum bilirubin, 
serum albumin, AST, ALT, alpha-fetoprotein (AFP) and carcinoembryonic antigen 
(CEA) were normal; alkaline phosphatase levels was slightly increased (135 U/L). She 
underwent color doppler transabdominal US which showed a hyperechoic mass with 
some peripheral color flow in the right lobe of the liver suggestive of hemangioma (Fig. 
1). An MRI of the abdomen was performed on I.5-T unit (GE Medical Systems, 
Milwaukee, Wis), utilizing transverse T2-weighted fast spin echo, unenhanced and 
gadolinium enhanced transverse fat suppressed T1-weighted 3D gradient-recalled echo 
sequences during arterial, portal venous and equilibrium phases.  MRI demonstrated a 3.9 
x 3.5 x 3.1 cm rounded mass within the posterior right hepatic lobe with a bulging 
contour that showed mild inhomogenous T2 hyperintensity (Fig. 2A) and T1 
hypointensity (Fig. 2B) relative to liver parenchyma. There was peripheral enhancement 
and few areas of non-enhancement with perilesional altered blood flow during arterial 
phase (Fig. 2C). The tumor showed mild decrease in peripheral enhancement on venous 
phase (Fig. 2D) and became isointense to liver parenchyma on delayed post contrast 
images (Fig. 2E). No other focal lesion was identified. There was no intrahepatic biliary 
ductal dilatation. The findings were considered suspicious for hepatocellular carcinoma 
or other primary liver malignancy, so she underwent US-guided liver biopsy. 
Microscopically, the tumor showed a microcystic pattern with low cuboidal epithelium 
with hobnail features, and prominent vasculature (Fig. 3A). There was immunoreactivity 
for calretinin (Fig. 3B) and WT-1 (Fig. 3C) indicating the mesothelial nature of the mass. 
The tumor was histologically determined as benign cystic mesothelioma.  Simple 
observation and close monitoring of her condition was advised as the patient was 
asymptomatic; if the mass enlarges or symptoms develop, surgical intervention will be 
considered. 
 
Discussion 
 
This case is one of only 3 cases of benign cystic mesothelioma of the liver described in 
the literature (including our present case) [2, 3]. This entity, first reported in 1979 [6], has 
a diverse terminology that includes multifocal peritoneal inclusion cyst, benign 
muticystic peritoneal mesothelioma and benign cystic mesothelioma [5, 6]. Intrahepatic 
tumor likely arises from undifferentiated mesothelial or submesothelial cells over the 
liver capsule [7]. Some have suggested that cystic mesothelioma may represent a reactive 
mesothelial proliferation rather than a neoplasm [4, 8], as it appears to be associated with 
pelvic inflammatory disease, prior history of pelvic surgery or endometriosis [8]. In this 
respect, its female predominance may be due to hormonal changes associated with 
reproductive age [3].  Benign mesothelioma is often cystic and non vascular, but in our 
case it was highly vascular based on imaging characteristics.  
Benign cystic mesothelioma has no specific clinical presentation. Patients usually 
complain of abdominal pain, anorexia, vague abdominal distress or palpable abdominal 
mass [5]. Less frequently it may be found incidentally on routine physical or imaging 
examinations without any symptoms, as in our case [9]. 
Benign cystic mesothelioma shows variable imaging appearances, which range from a 
unilocular to mutilocular thin walled cystic structure [5]. It is difficult to make a specific 
diagnosis based on the imaging findings when features are not consistent with completely 
cystic lesion. There is exiguous radiological description of benign cystic mesothelioma of 
the liver [4]. On US, it often appears as hypoechoic cystic mass [1], but in our case it was 
hyperechoic. On CT, it appears as a well-demarcated hypoattenuating cystic structure 
with minimal or no contrast enhancement [1, 5]. Few studies have described the MR 
imaging appearances of benign cystic mesothelioma [3, 5].  It contains non vascular 
watery serous content that shows low signal intensity on T1-weighted and intermediate to 
high signal intensity on T2-weighted images with no enhancement except for septations 
that enhance when present [5]. MRI findings in our case were not typical. We observed a 
liver mass that was hypointense on T1 weighted and hyperintense on T2-weighted 
sequences, corresponding to edematous connective tissue and viable tumor. We noted 
peripheral and complete enhancement on early and delayed gadolinium enhanced images 
consistent with highly vascular tumor. In our case MRI findings has considerable overlap 
with hypervascular malignant tumors such as hepatocellular carcinoma (HCC).  Typical 
HCCs show a fast wash-out in the parenchymal phase which was not seen in this case. A 
typical haemangioma was also considered since these show high signal intensity on T2-
weighted images and may show intense early and late enhancement, but these benign 
tumors typically have enhancement that is more nodular and progressive than seen in this 
case.  
Tissue diagnosis is crucial to assess the definitive treatment. Microscopically, cystic 
mesothelioma have multiple, translucent cystic spaces that are lined by flat cuboidal 
mesothelial cells and often filled with serous fluid embedded in a fibrous stroma [5]. 
They have no malignant potential. In our case, demonstration of mesothelial origin of the 
tumor by immunostaining was critical for diagnosis.  
The mainstay of treatment is surgical resection with a wide margin of excision for an 
easily approachable and resectable mass [8].  Chemotherapy or radiotherapy has no role 
in treatment [1]. Conservative alternatives to surgery include oral contraceptives and 
gonadotrophin releasing agonist hormones [3, 5]. These tumors have a high rate of 
recurrence postoperatively [1, 5, 8]. Therefore strict follow up is needed for further 
surveillance.  
In conclusion, the diagnosis of benign cystic mesothelioma of the liver remains a 
challenge and cannot be made solely from clinical findings and imaging. The signal-
intensity and enhancement pattern of the reported mass are rather unusual and not typical 
for any of the more frequently seen lesions. An appropriately guided biopsy will usually 
give the answer, thus avoiding more complicated diagnostic or therapeutic interventions. 
However a long-term close follow-up is required due to their high incidence of 
recurrence.
References 
[1] O’Neil JD, Ros PR, Storm BL, Buck JL, Wilkinson EJ. Cystic mesothelioma of  
     the  peritoneum Radiology 1989;170(2):333–7. 
[2] Rout P, Rameshkumar K, Srikrishna NV. Hepatic mesothelioma. Indian J  
     Gastroenterol 1999;18(4):176–7. 
[3] Flemming P, Becker T, Klempnauer J, Högemann D, Kreft A, Kreipe HH.  
       Benign cystic mesothelioma of the liver. Am J Surg Pathol 2002;26(11):1523-7. 
[4] Moran C, Ishak K, Goodman Z. Solitary fibrous tumor of the liver. A        
      clinicopathologic and immunohistochemical study of nine cases. Ann Diagn Pathol  
      1998;2(1):19–24. 
[5] Levy AD, Arnáiz J, Shaw JC, Sobin LH. From the archives of the AFIP:  
   Primary peritoneal tumors: imaging features with pathologic correlation.    
   Radiographics 2008; 28(2):583-607. 
[6] Mennemeyer R, Smith M. Multicystic, peritoneal mesothelioma: a report with  
      electron microscopy of a case mimicking intra-abdominal cystic hygroma  
     (lymphangioma). Cancer 1979;44(2):692–698 
[7] Holtzman RN, Heymann AD, Bordone F, Marinoni G, Barillari P, Wahl S     
      Carbohydrate antigen and carcinoembryonic antigen immunostaining in benign     
      multicystic mesothelioma of the peritoneum. Arch Pathol Lab Med 2001;125(7):944–  
       7 
[8] Ross MJ, Welch WR, Scully RE.  Multilocular peritoneal inclusion cysts (so    
      called cystic mesotheliomas). Cancer 1989;64(6):1336–46 
 
[9] Muscarella P, Cowgill S, DeRenne LA, Ellison EC. Retroperitoneal benign 
     cystic peritoneal mesothelioma. Surgery 2004;135(2):228–31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure Legends 
Fig. 1. Color doppler sonogram of the abdomen in an oblique sagittal plane reveals 
hyperechoic mass (block arrow) with some peripheral color flow (arrow) within the right 
lobe of the liver 
 
Fig.  2. Transverse MR images of the liver show 3.9 x 3.5 x 3.1 cm inhomogenous 
lobulated mass in the posterior segment of the right hepatic lobe. The tumor is mildly 
hyperintense (arrow) on (A) T2 weighted fast spin-echo image (TR/TE, 490/200) and 
hypointense (arrow) on (B) fat-suppressed unenhanced T1-weighted gradient-recalled 
echo image (TR/TE, 3/1.6). (C) Fat-suppressed contrast enhanced T1-weighted gradient-
recalled echo image during hepatic arterial phase reveals intense peripheral enhancement 
of the tumor (arrows) with few non-enhancing areas (asterisk) and perilesional altered 
blood flow (arrowhead). (D) Fat-suppressed contrast enhanced T1-weighted gradient-
recalled echo image during portal venous phase reveals mild decreased peripheral 
enhancement of the tumor (arrows) with few non-enhancing areas (asterisk). (E) Fat-
suppressed contrast enhanced T1-weighted gradient-recalled echo image during 
equilibrium phase shows that tumor has become isointense to liver parenchyma with no 
washout pattern. 
 
Fig. 3 (A) Histologically, the tumor demonstrates cystic spaces lined by low cuboidal 
cells with hobnail features and prominent vascularity (H and E, x200). Positive 
immunostaining for mesothelial markers; calretinin (B) and WT-1 (C). 
 
